MICKEL THERAPY SCIENCE AND RESEARCH
“The Science behind Mickel Therapy”
‘ The important thing in science is not so much to obtain new facts as to discover new ways of thinking about them’.
Sir William Bragg (1862 – 1942)
Mickel Therapy has long been under scrutiny for its hypothesis that symptoms of CFS/M.E and Fibromyalgia are a result of a dysfunctional hypothalamus gland that we have termed rather loosely ‘Hypothalamitis’. This refers to the apparent failure of the feedback mechanisms that are designed to lead the hypothalamus gland to alter its neuro-chemical signals through the Pituitary-Adrenal Axis and the Autonomic Nervous System through the lateral medulla.
However, as our organisation’s main focus is to have Mickel Therapy independently studied and subsequently shown to be the treatment of choice for CFS/M.E and Fibromyalgia, we feel that an expansion on the underlying science is necessary. This article will give a brief overview of this and we will continue to gather evidence to be displayed on this page. Mickel Therapy’s Managing Director and Consultative Director of Research Dr Francis Teeney from Queen’s University, School of Psychology, Belfast University will oversee this. You can also read more about our other management team members from Queens and other established institutions.
The Mickel Therapy process is based on ideas similar to that described by Dr Hans Selye in the 1950’s when he described General Adaptation Syndrome which to all intents and purposes could have been an early description of what has now become known as CFS/M.E. Unfortunately there have been chronic misunderstandings around CFS/M.E.
Many of our concepts around the therapy have been supported by leading expert on emotions, Professor Roddy Cowie of Queen’s University Belfast.
We are hopeful of being able to start to collect more research in this field to share with you on this web page.